K Matsui Selected Research

methanesulfonic acid (methanesulfonate)

1/2002	Effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemic preconditioning in rabbits.
6/2001	Na+/H+ exchange inhibitor SM-20220 attenuates leukocyte adhesion induced by ischemia-reperfusion.
1/2001	The effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemia/reperfusion-induced endothelial dysfunction in isolated perfused rat hearts.
9/2000	Reduction of myocardial infarct size by SM-20550, a novel Na(+)/H(+) exchange inhibitor, in rabbits.
6/2000	SM-20550, a new Na+/H+ exchange inhibitor and its cardioprotective effect in ischemic/reperfused isolated rat hearts by preventing Ca2+-overload.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Matsui Research Topics

Disease

12	Ischemia 01/2002 - 01/2000
9	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 09/2001 - 02/2000
7	Atopic Dermatitis (Atopic Eczema) 01/2012 - 01/2000
7	Reperfusion Injury 01/2002 - 01/2000
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2008 - 07/2001
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2009 - 02/2000
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2002 - 03/2000
5	Infarction (Infarctions) 01/2002 - 09/2000
5	Neoplasms (Cancer) 10/2001 - 02/2000
4	Infections 10/2009 - 04/2000
3	Lung Neoplasms (Lung Cancer) 01/2009 - 01/2000
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2001 - 01/2001
3	Acidosis 01/2001 - 06/2000
3	Cysts 11/2000 - 10/2000
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 02/2000
2	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 05/2007
2	Type 2 Diabetes Mellitus (MODY) 01/2016 - 08/2000
2	Necrosis 05/2007 - 09/2000
2	Breast Neoplasms (Breast Cancer) 04/2005 - 10/2001
2	Dermatitis 06/2003 - 05/2002
2	Retinal Detachment (Retinal Detachments) 10/2002 - 01/2000
2	Hyperplasia 12/2001 - 11/2000
2	Hypoxia (Hypoxemia) 03/2001 - 01/2001
2	Nephrosis 06/2000 - 06/2000
1	Insulin Resistance 01/2021
1	Obesity 01/2021
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Brain Death (Brain Dead) 01/2018
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2016
1	Febrile Neutropenia 01/2014
1	Ovarian Epithelial Carcinoma 01/2014
1	Neutropenia 01/2014
1	Ovarian Neoplasms (Ovarian Cancer) 01/2014
1	Carcinoma (Carcinomatosis) 01/2013
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 02/2012
1	Asthma (Bronchial Asthma) 01/2010
1	Chronic Cough 01/2010
1	Hematoma 06/2009
1	Disease Progression 05/2009
1	Neoplasm Metastasis (Metastasis) 01/2009
1	Fatty Liver 10/2008
1	Pain (Aches) 05/2007
1	Mixed Connective Tissue Disease (MCTD) 05/2007
1	CREST Syndrome (Syndrome, CREST) 05/2007
1	Exanthema (Rash) 09/2006
1	Cataract (Cataracts) 09/2005

Drug/Important Bio-Agent (IBA)

9	lipoarabinomannan (LAM)IBA 09/2001 - 02/2000
7	SM 20550IBA 01/2002 - 01/2000
5	Cisplatin (Platino)FDA LinkGeneric 02/2008 - 05/2003
5	methanesulfonic acid (methanesulfonate)IBA 01/2002 - 06/2000
4	EnzymesIBA 10/2009 - 02/2000
4	Etoposide (VP 16)FDA LinkGeneric 02/2008 - 07/2001
4	Irinotecan (Camptosar)FDA LinkGeneric 02/2008 - 05/2003
4	indoleIBA 01/2002 - 06/2000
4	SM 20220IBA 07/2001 - 01/2001
3	lipoteichoic acidIBA 06/2003 - 03/2000
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014 - 02/2008
2	ImmunosorbentsIBA 10/2009 - 09/2000
2	AntibodiesIBA 10/2009 - 09/2000
2	Docetaxel (Taxotere)FDA Link 05/2009 - 01/2004
2	Vasodilator Agents (Vasodilators)IBA 05/2007 - 01/2001
2	Alanine Transaminase (SGPT)IBA 09/2006 - 03/2000
2	Peptidoglycan (Murein)IBA 01/2006 - 03/2000
2	AllergensIBA 06/2003 - 05/2002
2	Matrix Metalloproteinases (MMPs)IBA 12/2001 - 02/2000
2	Messenger RNA (mRNA)IBA 09/2001 - 02/2001
2	Interleukin-18 (Interleukin 18)IBA 07/2001 - 04/2000
2	Carboplatin (JM8)FDA LinkGeneric 07/2001 - 02/2000
2	Pharmaceutical PreparationsIBA 06/2001 - 02/2001
2	ethylisopropylamiloride (EIPA)IBA 03/2001 - 02/2001
2	Proteins (Proteins, Gene)FDA Link 02/2001 - 04/2000
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2001 - 06/2000
2	Sodium-Hydrogen ExchangersIBA 01/2001 - 09/2000
2	Creatine Kinase (Creatine Phosphokinase)IBA 09/2000 - 07/2000
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	ursodoxicoltaurineIBA 01/2021
1	Metronidazole (Metric)FDA LinkGeneric 01/2020
1	NAD (NADH)IBA 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Aquaporin 5IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 02/2012
1	Interleukin-12 (IL 12)IBA 01/2012
1	Gemcitabine FDA Link 05/2009
1	Gefitinib (Iressa)FDA Link 01/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2009
1	Oxygen (Dioxygen)IBA 05/2007
1	ProstaglandinsIBA 05/2007

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2014 - 09/2001
4	Therapeutics 01/2009 - 03/2000
3	Intravenous Infusions 07/2001 - 01/2001
2	Transplantation 01/2018 - 10/2000
2	Intravenous Administration 06/2001 - 09/2000
2	Radiotherapy 02/2000 - 01/2000
1	Organ Transplantation 01/2018
1	Traditional Medicine (Folk Remedies) 01/2010
1	Conservative Treatment 06/2009
1	Hepatectomy 10/2008